FdaApplication
ANDA 215737
Identifiers
- fda_app_no: ANDA215737
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-08-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CETRORELIX ACETATE | CETRORELIX ACETATE | EQ 0.25MG BASE/VIAL | POWDER;SUBCUTANEOUS |
1 product